Ontology highlight
ABSTRACT:
SUBMITTER: Strosberg JR
PROVIDER: S-EPMC5642985 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
Strosberg Jonathan R JR Halfdanarson Thorvardur R TR Bellizzi Andrew M AM Chan Jennifer A JA Dillon Joseph S JS Heaney Anthony P AP Kunz Pamela L PL O'Dorisio Thomas M TM Salem Riad R Segelov Eva E Howe James R JR Pommier Rodney F RF Brendtro Kari K Bashir Mohammad A MA Singh Simron S Soulen Michael C MC Tang Laura L Zacks Jerome S JS Yao James C JC Bergsland Emily K EK
Pancreas 20170701 6
There have been significant developments in diagnostic and therapeutic options for patients with neuroendocrine tumors (NETs). Key phase 3 studies include the CLARINET trial, which evaluated lanreotide in patients with nonfunctioning enteropancreatic NETs; the RADIANT-2 and RADIANT-4 studies, which evaluated everolimus in functioning and nonfunctioning NETs of the gastrointestinal tract and lungs; the TELESTAR study, which evaluated telotristat ethyl in patients with refractory carcinoid syndrom ...[more]